Followers | 66 |
Posts | 3760 |
Boards Moderated | 0 |
Alias Born | 11/13/2015 |
![](https://investorshub.advfn.com/uicon/547469.png?cb=1469053966)
Sunday, January 01, 2017 10:24:44 PM
Recent BCDA News
- BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 08/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 05:57:35 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/09/2024 08:40:18 PM
- BioCardia to Host Q2 2024 Corporate Update and Financial Results Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 08/02/2024 09:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 11:00:36 AM
- BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 11:00:14 AM
- Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure • GlobeNewswire Inc. • 07/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 11:00:23 AM
- BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:00:39 AM
- CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction • GlobeNewswire Inc. • 07/08/2024 11:00:00 AM
- BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach • GlobeNewswire Inc. • 06/07/2024 11:00:00 AM
- BioCardia Announces Reverse Stock Split • GlobeNewswire Inc. • 05/21/2024 09:00:00 PM
- BioCardia Reports First Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 05/14/2024 08:02:00 PM
- BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort • GlobeNewswire Inc. • 04/25/2024 01:00:00 PM
- BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results • GlobeNewswire Inc. • 03/27/2024 08:00:00 PM
- BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024 • GlobeNewswire Inc. • 03/20/2024 11:00:00 AM
- BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study • GlobeNewswire Inc. • 03/12/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:00:21 PM
- BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM